NEW!!! Download our Healthcare M&A Review 2024
Home
Subscriptions
Segment Reports
Other Products
News & Insights
More
Home Health and Hospice EBITDA Multiples: Optum Outbids Option Care for Amedisys (15.2x EBITDA)